S-Nitrosoglutathione Reductase Inhibition Regulates Allergen-Induced Lung Inflammation and Airway Hyperreactivity

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Ferrini, Maria E ^a   Simons, Bryan J ^a   Bassett, David J P ^b   Bradley, Matthews O ^c   Roberts, Kevan ^a   Jaffar, Zeina ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAJE Pharma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALLERGEN; CD4 ANTIGEN; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OXIDOREDUCTASE INHIBITOR; S NITROSOGLUTATHIONE REDUCTASE; SPL 334; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME INHIBITION; EOSINOPHIL; FEMALE; MALE; MOUSE; MUCUS SECRETION; NONHUMAN; PNEUMONIA; T LYMPHOCYTE; TH2 CELL; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHIAL HYPERREACTIVITY; CELL MOVEMENT; CHEMOKINE CCL11; ENZYME INHIBITORS; EOSINOPHILS; FEMALE; GLUTATHIONE REDUCTASE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PNEUMONIA; TH2 CELLS;

EID: 84880804015     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070351     Document Type: Article

References (30)

1. Wills-Karp M, (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202: 175-190.
2. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, et al. (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97: 604-612.
3. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, et al. (2002) Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 195: 1433-1444.
4. Lloyd CM, Hawrylowicz CM, (2009) Regulatory T cells in asthma. Immunity 31: 438-449.
5. Jaffar Z, Ferrini ME, Shaw PK, Fitzgerald GA, Roberts K, (2011) Prostaglandin I2 Promotes the Development of IL-17-Producing gammadelta T Cells That Associate with the Epithelium during Allergic Lung Inflammation. J Immunol 187: 5380-5391.
6. Jaffar Z, Sivakuru T, Roberts K, (2004) CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 172: 3842-3849.
7. Jaffar Z, Wan KS, Roberts K, (2002) A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J Immunol 169: 5997-6004.
8. Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, et al. (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204: 357-367.
9. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, et al. (1996) Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med 153: 128-135.
10. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, et al. (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308: 1618-1621.
11. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, et al. (1994) Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135.
12. Stamler JS, Lamas S, Fang FC, (2001) Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106: 675-683.
13. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, et al. (1993) Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A 90: 10957-10961.
14. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, et al. (1998) Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351: 1317-1319.
15. Liu L, Hausladen A, Zeng M, Que L, Heitman J, et al. (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410: 490-494.
16. Bannenberg G, Xue J, Engman L, Cotgreave I, Moldeus P, et al. (1995) Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung. J Pharmacol Exp Ther 272: 1238-1245.
17. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, et al. (1994) Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 268: 978-984.
18. Gaston B, Drazen JM, Loscalzo J, Stamler JS, (1994) The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149: 538-551.
19. Fang K, Johns R, Macdonald T, Kinter M, Gaston B, (2000) S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 279: L716-721.
20. Foster MW, Yang Z, Potts EN, Michael Foster W, Que LG, (2011) S-nitrosoglutathione supplementation to ovalbumin-sensitized and-challenged mice ameliorates methacholine-induced bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 301: L739-744.
21. Henderson EM, Gaston B, (2005) SNOR and wheeze: the asthma enzyme? Trends Mol Med 11: 481-484.
22. Sanghani PC, Davis WI, Fears SL, Green SL, Zhai L, et al. (2009) Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase. J Biol Chem 284: 24354-24362.
23. Que LG, Yang Z, Stamler JS, Lugogo NL, Kraft M, (2009) S-nitrosoglutathione reductase: an important regulator in human asthma. Am J Respir Crit Care Med 180: 226-231.
24. Wu H, Romieu I, Sienra-Monge JJ, Estela Del Rio-Navarro B, Anderson DM, et al. (2007) Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. J Allergy Clin Immunol 120: 322-328.
25. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, et al. (1999) Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 163: 6876-6883.
26. Wever AM, Wever-Hess J, Hensgens HE, Hermans J, (1994) Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. Respir Med 88: 613-621.
27. Li Q, Verma IM, (2002) NF-kappaB regulation in the immune system. Nature Rev Immunol 2: 725-734.
28. Kasaian MT, Miller DK, (2008) IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 76: 147-155.
29. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, et al. (1998) Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
30. Sun X, Qui J, Strong SA, Green LS, Wasley JWF, et al. (2012) Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: Caboxamide modification. Bioorg Med Chem Lett 22: 2338-2342.